Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,... see more

GREY:ATBPF - Post Discussion

Antibe Therapeutics Inc(Pre-Merger) > Otenaproxesul and COVID-19 Data
View:
Post by mstrmnd on Aug 19, 2021 10:54am

Otenaproxesul and COVID-19 Data

Great last question

Clearly they have some insights about potential efficacy in COVID-19
Comment by 123ABC on Aug 19, 2021 10:57am
We'll be looking at these bags for at least 12 months. Feels good.
Comment by Inthepez on Aug 19, 2021 12:10pm
I listened to the AGM meeting and it brought up great info. I’m overall bullish.While there will be a 12month delay for ph3, I’m betting we bounce to the $2.5-3 range by December. Partnership negotiations will resume after the investigation of the AME is complete (which will take 5 weeks according to Dan and Stauffer).  A good take away was Stauffer and Dan mentioning that H2S provides a ...more  
Comment by Rarbar99 on Aug 19, 2021 12:35pm
"It's not a serious issue." That's why none of their insiders are buying even after a 70% drop. You people are such gullible fools it is absolutely hilarious.  The biggest purchase they made was the CEO, and he only bought $10K worth which is pennies in the grand scheme. If this was all FUD and an overreaction, the insiders would have bought hundreds of thousands, if not ...more  
Comment by Inthepez on Aug 19, 2021 12:38pm
Lol the issue isn’t if they buy. The issue is if they sell. the only thing that’s laughable here is you
Comment by Rarbar99 on Aug 19, 2021 12:41pm
Jesus Christ you're not the brightest tool in the shed, that's for sure. Of course they're not going to sell. The stock has already crashed 70% and if any of them dared sell, the company would tank even further and delist. All institutions would flee and so would most retailers. If a drug company pauses a testing over complications, tanks in value, and then insiders start selling ...more  
Comment by Inthepez on Aug 19, 2021 12:55pm
Your r3tardation knows no limits. But I know it’s just FUD. They millions upon millions of shares. If they really felt the ship was going down they would sell and no give a cr@p about retailers or the company, and treat it as a sunk cost.  Just shut up and move on if you think it’s hopeless. You’re obviously scalping. What’s the point constantly saying the same thing.  Youre so ...more  
Comment by Rarbar99 on Aug 19, 2021 1:05pm
For the second time, selling is not an option for a company during these dips. It would almost be like declaring bankruptcy. They will never do this even if they wanted too. But I looked through your profile and you were arguing with Yukon for several months. In the end, he was right and you were wrong. Take it like a champ and stop crying. Things haven't been going too well for you, sucks ...more  
Comment by Inthepez on Aug 19, 2021 1:23pm
R3tard, if they really knew the company had no future they would divest the company, treat as a sunk cost, and pay off shareholders at book value with their $66mil. That’s sound business sense. yukonjizz face never predicted the AME issue, no one did. He just recycles the same BS you’re spewing. We know it’s your burner account. You made August 10 2021 just to bash. Must’ve hard being as dumb as ...more  
Comment by Rarbar99 on Aug 19, 2021 1:30pm
The company is trying to salvage anything that's left. They're not going to abandon ship you absolute moron. yukon predicted this stock would drop, which it did. Take the L.
Comment by Inthepez on Aug 19, 2021 1:44pm
Nah r3tard. Its not salvage, its because they think the AME is a speed bump. If they really what you did do then they would divest. They do have that option if took the time to read accomping AGM files on sedar "you absolute more moron" lol! Glad youre not denying its your burner account you FUD fairy. there were other trolls who though it drop but without any substance. If you/him had ...more  
Comment by StockingUp21 on Nov 26, 2021 6:10pm
Mr. class using R word. You should delete these comments 
Comment by StockingUp21 on Aug 19, 2021 1:39pm
They did sell lots after phase 11 to compare yes? Rather then buy do you think this was seen coming or are they lucky. And I wish they bought more to show confidence
Comment by Rawrasaurus on Aug 19, 2021 11:00am
You're welcome. Lol Sorry if my questions were getting too hyper specific for people. I've been meaning to reach out to them for awhile about some of this stuff, but going through IR doesn't get me anywhere. For the last year, I couldn't figure out why that wasn't in the known pipeline given the research that inidicates it's effectiveness as both a preventative and ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities